Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy

Muscle and Nerve

Volumn 44, Issue 3, 2011, Pages 340-345

  Dyck, Peter J ^a   Carter, Rickey E ^a   Litchy, William J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Composite scores of nerve conduction; Diabetic sensorimotor polyneuropathy; Diagnostic criteria; Nerve conduction; Sensitivity; Specificity of nerve test

Indexed keywords

ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MOTOR NERVE; MOTOR NERVE CONDUCTION; NEUROPHYSIOLOGY; PRIORITY JOURNAL; SENSORIMOTOR NEUROPATHY; SURAL NERVE;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; PERONEAL NERVE; SENSITIVITY AND SPECIFICITY; SURAL NERVE; TIBIAL NERVE; ULNAR NERVE; YOUNG ADULT;

EID: 80052046734     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22074     Document Type: Article

References (25)

1. Mulder DW, Lambert EH, Bastron JA, Sprague RG. The neuropathies associated with diabetes mellitus: a clinical and electromyo-graphic study of 103 unselected diabetic patients. Neurology 1961; 11:275-284.
2. Gilliatt RW, Willison RG. Peripheral nerve conduction in diabetic neuroapthy. J Neurol Neurosurg Psychiatry 1962;25:11-18.
3. LaMontagne A, Buchthal F. Electrophysiological studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 1970;33:442-452.
4. Behse F, Buchthal F, Carlsen F. Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 1977;40: 1072-1082.
5. Kimura J, Yamada T, Stevland NP. Distal slowing of motor nerve conduction velocity in diabetic polyneuropathy. J Neurol Sci 1979;42: 291-302.
6. Dyck PJ, Karnes JL, Daube J, O'Brien P, Service FJ. Clinical and neu-ropathological criteria for the diagnosis and staging of diabetic neuropathy. Brain 1985;108:861-880.
7. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ III, O'Brien PC, et al. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991;41:799-807.
8. Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects (RDNS-HS). Neurology 1995; 45:1115-1121.
9. Dyck PJ, O'Brien PC, Litchy WJ, Harper CM, Daube JR, Dyck PJB. Use of percentiles and normal deviates to express nerve conduction and other test abnormalities. Muscle Nerve 2001;24:307-310.
10. O'Brien PC, Dyck PJ. Procedures for setting normal values. Neurology 1995;45:17-23.
11. Dyck PJ, Benstead TJ, Conn DL, Stevens JC, Windebank AJ, Low PA. Nonsystemic vasculitic neuropathy. Brain 1987;110:843-854.
12. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, et al. Distal symmetrical polyneuropathy: a definition for clinical research. A report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Arch Phys Med Rehabil 2005;86:167-174.
13. Dyck PJ, O'Brien PC, Davies J, Klein CJ, Dyck PJB. Nerve tests expressed as percentiles, normal deviates, and composite scores. In:Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. Philadelphia: Elsevier; 2005. p 971-984.
14. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 1997;49:229-239.
15. Dyck PJ, O'Brien PC, Litchy WJ, Harper CM, Klein CJ, Dyck PJB. Monotonicity of nerve tests in diabetes. Subclinical nerve dysfunction precedes diagnosis of polyneuropathy. Diabetes Care 2005;28: 2192-2200.
16. Rivner MH, Swift TR, Crout BO, Rhodes KP. Toward more rational nerve conduction interpretations: the effect of height. Muscle Nerve 1990;13:232-239.
17. Dyck PJ, Bushek W, Spring EM, Karnes JL, Litchy WJ, O'Brien PC, et al. Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care 1987;10:432-440.
18. Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 1988;11:21-32.
19. Dyck PJ, Karnes JL, O'Brien PC, Litchy WJ, Low PA, Melton LJ. Reassessment of tests and criteria for diagnosis and staged severity. Neurology 1992;42:1164-1170.
20. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria and estimation of severity (the Toronto Expert Group Meeting 2009). Diabetes Care 2010;233:2285-2293.
21. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43: 817-824.
22. Dyck PJ, Litchy WJ, Daube JR, Harper CM, Dyck PJB, Davies J, et al. Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment. Muscle Nerve 2003;27:202-210.
23. Dyck PJ, Davies JL, Clark VM, Litchy WJ, Klein CJ, Rizza RA, et al. Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care 2006;29:2282-2288.
24. Dyck PJ, Norell JE, Tritschler H, Schuette K, Samigullin R, Ziegler D, et al. Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. Diabetes Care 2007;30:2619-2625.
25. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJB, et al. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys Trial. Muscle Nerve 2010;42:157-164.